Related Experiment Video
Updated: Jul 8, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Black cohosh-induced hepatitis
Bruce C Nisbet1, Robert E O'Connor
1Department of Emergency Medicine at Christiana Care Health System, Newark, Del, USA.
Black cohosh, a popular herbal remedy, can cause acute hepatitis, even in healthy individuals. This case highlights the importance of considering herbal supplements in differential diagnoses for liver injury.
Area of Science:
- Hepatology
- Integrative Medicine
- Clinical Toxicology
Background:
- Herbal products, including black cohosh, are widely used by consumers.
- Despite popularity, herbal remedies are not regulated by the Food and Drug Administration (FDA) and can cause serious side effects.
- Hepatotoxicity associated with herbal remedies is a growing concern in clinical practice.
Observation:
- A 50-year-old woman presented with symptoms of fatigue and right upper quadrant pain.
- Two weeks prior to presentation, the patient had started using black cohosh.
- Initial laboratory results indicated acute hepatitis.
Findings:
- After excluding other potential causes of liver dysfunction, the patient was diagnosed with black cohosh-induced hepatitis.
- The patient experienced a full recovery after discontinuing the herbal supplement.
- This case adds to the five previously reported instances of hepatitis or liver failure linked to black cohosh.
Implications:
- This case underscores the critical need for a comprehensive differential diagnosis in patients presenting with abdominal pain.
- It highlights the importance of a complete patient medication history, explicitly including herbal supplements.
- Healthcare providers should be aware of potential hepatotoxicity associated with herbal remedies like black cohosh.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...